Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment [NA]

View source ↗

Summary

A clinical trial is evaluating Cerogrin for auricular vagus nerve stimulation in vascular dementia and vascular mild cognitive impairment; recruitment is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerogrin

Snippet

Sponsor: Neurogrin Inc. | Conditions: Vascular Dementia, Mild Cognitive Impairment | NA | Status: RECRUITING